Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In a study comparing Bifidobacterium longum, Ispaghula husk/Psyllium, and a combination of Bifidobacterium longum with Ispaghula husk/Psyllium for patients with Ulcerative Colitis (UC) (XXX - Bifidobacterium longum vs Ispaghula husk / Psyllium vs Bifidobacterium longum + Ispaghula husk / Psyllium & Ulcerative Colitis (UC)), it was found that those who received synbiotic therapy experienced more significant improvements in their quality of life. This was in contrast to patients who were treated with either probiotic or prebiotic therapy alone. The findings suggest that synbiotic therapy may have a synergistic effect in managing UC.(1).
(1)
…